The Effect of Therapeutic Touch and Emotional Freedom Technique on Postpartum Mood and Fatigue in Postpartum Women

September 6, 2025 updated by: KTO Karatay University
Therapeutic touch (TD) is a non-pharmacological/integrated treatment method used to balance the body by regulating the imbalanced energy field in the individual or resolving blockages in energy flow. Emotional freedom technique (EFT) is a psychophysiological intervention that combines elements of somatic stimulation using acupuncture points. This research will be conducted as a randomized controlled experimental study to determine the effect of TD and EFT intervention on postpartum mood and fatigue in postpartum women. This study is planned to be conducted between April 2024 and June 2025 with postpartum women who meet the inclusion criteria and who apply to the Obstetrics and Gynecology Clinic of Necmettin Erbakan University Faculty of Medicine Hospital. This research; It was planned to be carried out with three groups: TD intervention, EFT intervention and control group. The population of the research consists of women who gave birth vaginally and those who gave birth vaginally in the relevant hospital.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Konya
      • Karatay, Konya, Turkey (Türkiye), 42020
        • KTO Karatay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Having a vaginal birth at term
  • Being primiparous
  • Postpartum 3rd-5th. to be in the days
  • Being able to speak and understand Turkish
  • Being 18 years or older
  • Having a single and viable fetus
  • Volunteering to participate in research
  • Not having experienced TD or EFT treatment before

Exclusion Criteria:

  • A psychiatric diagnosis has been made,
  • Having a chronic systemic disease,
  • The newborn's need for treatment
  • Having postpartum complications in the mother or baby
  • Those who have sensitivity or problems with touch,
  • Wounds, infections, etc. in places that need to be touched. existence of situations,
  • Women who have any disability that would prevent communication (deafness, hearing impairment, etc., use of languages other than Turkish) will be excluded from the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EFT intervention
The application will be carried out in line with EFT application protocols. In this regard, women's home visits will be completed with 6 meetings, once every week. Each EFT session will last 15 minutes
Other: Emotional freedom technique (EFT)
İntervention groups will be followed for six months and one of the six EFT therapies will be applied, one session every week.
Experimental: TD intervention
The application will be carried out in line with TD application protocols. In this regard, women's home visits will be completed with 6 meetings, once every week. Each TD session will last 15 minutes
Other: Therapeutic touch (TD)
İntervention groups will be followed for six weeks and one of the six TD therapies will be applied, one session every week.
No Intervention: Control grup
No intervention will be made. Women in the intervention groups will be followed for 6 weeks and receive standard care. The final test will be administered at the end of the sixth week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum 3rd-5th. TD intervention will be applied to women who are between
Time Frame: six weeks
SUE scale and vital signs will be taken from the participants before and after each session.
six weeks
3rd-5th postpartum Pre- and post-test will be given to women between
Time Frame: six weeks
The researcher will not perform any intervention on women in this group. After the pre-tests are completed, women in this group will be called by phone during the interview weeks for the intervention group, their postpartum needs will be questioned and support will be provided when necessary. The implementation of the final tests will be completed in the sixth week.
six weeks
Postpartum 1rd-5th. EFT intervention will be applied to women who are between
Time Frame: six weeks
SUE scale and vital signs will be taken from the participants before and after each session.
six weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

KTO Karatay University

Investigators

  • Principal Investigator: Aslıhan Turan, PhD (c), KTO Karatay University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

June 10, 2025

Study Registration Dates

First Submitted

May 8, 2024

First Submitted That Met QC Criteria

May 28, 2024

First Posted (Actual)

June 3, 2024

Study Record Updates

Last Update Posted (Estimated)

September 12, 2025

Last Update Submitted That Met QC Criteria

September 6, 2025

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • A-TURAN-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Emotional freedom technique (EFT)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe